United Kingdom
# |
Name |
Operating Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 8.58 B
|
Dec. 31, 2023 | USD 17.39 | -0.08% |
|
United Kingdom |
|
2 |
USD 8.19 B
|
Dec. 31, 2023 | USD 140.24 | -0.22% |
|
United Kingdom |
|
3 |
USD 4.24 B
|
March 31, 2024 | USD 11.13 | -2.11% |
|
United Kingdom |
|
4 |
USD 2.54 B
|
Dec. 31, 2023 | USD 4.67 | 0.65% |
|
United Kingdom |
|
5 |
USD 533.49 M
|
July 31, 2024 | USD 25.30 | -1.17% |
|
United Kingdom |
|
6 |
USD 463.95 M
|
March 31, 2024 | USD 37.51 | -0.51% |
|
United Kingdom |
|
7 |
USD 425.00 M
|
Dec. 31, 2023 | USD 12.79 | 0.04% |
|
United Kingdom |
|
8 |
USD 367.00 M
|
Dec. 31, 2023 | USD 28.38 | -0.06% |
|
United Kingdom |
|
9 |
USD 277.37 M
|
Sept. 30, 2024 | USD 56.22 | -0.33% |
|
United Kingdom |
|
10 |
USD 262.70 M
|
Dec. 31, 2023 | USD 3.02 | -1.33% |
|
United Kingdom |
|
11 |
USD 160.95 M
|
Dec. 31, 2023 | USD 2.89 | -0.48% |
|
United Kingdom |
|
12 |
USD 21.39 M
|
Dec. 31, 2023 | USD 1.42 | -3.02% |
|
United Kingdom |
|
13 |
USD 13.41 M
|
June 30, 2024 | USD 38.56 | 0.38% |
|
United Kingdom |
|
14 |
USD 12.85 M
|
Dec. 31, 2023 | USD 0.24 | -0.40% |
|
United Kingdom |
|
15 |
USD 9.86 M
|
April 30, 2024 | USD 0.65 | -1.49% |
|
United Kingdom |
|
16 |
USD 4.46 M
|
March 31, 2024 | USD 0.80 | 0.38% |
|
United Kingdom |
|
17 |
USD 2.65 M
|
Dec. 31, 2023 | USD 0.32 | 2.99% |
|
United Kingdom |
|
18 |
USD 0.00
|
June 30, 2024 | USD 0.03 | 1.77% |
|
United Kingdom |
|
19 |
USD -15.75 K
|
March 31, 2024 | USD 1.06 | -3.64% |
|
United Kingdom |
|
20 |
USD -849.05 K
|
June 30, 2024 | USD 0.01 | -9.39% |
|
United Kingdom |
|
21 |
USD -2.29 M
|
Dec. 31, 2023 | USD 0.03 | 4.40% |
|
United Kingdom |
|
22 |
USD -2.46 M
|
Dec. 31, 2023 | USD 0.04 | -11.51% |
|
United Kingdom |
|
23 |
USD -2.88 M
|
Dec. 31, 2023 | USD 1.98 | 0.38% |
|
United Kingdom |
|
24 |
USD -2.88 M
|
Sept. 30, 2024 | USD 0.16 | 4.56% |
|
United Kingdom |
|
25 |
USD -2.89 M
|
March 31, 2024 | USD 0.09 | -2.82% |
|
United Kingdom |
|
26 |
USD -3.42 M
|
May 31, 2024 | USD 0.24 | 1.95% |
|
United Kingdom |
|
27 |
USD -3.68 M
|
June 30, 2024 | USD 0.22 | 1.80% |
|
United Kingdom |
|
28 |
USD -3.84 M
|
Dec. 31, 2023 | USD 0.16 | 0.38% |
|
United Kingdom |
|
29 |
USD -4.21 M
|
Dec. 31, 2023 | USD 0.57 | 0.38% |
|
United Kingdom |
|
30 |
USD -4.39 M
|
March 31, 2024 | USD 0.09 | -6.74% |
|
United Kingdom |
|
31 |
USD -5.38 M
|
Aug. 31, 2023 | USD 0.13 | 4.36% |
|
United Kingdom |
|
32 |
USD -5.86 M
|
June 30, 2024 | USD 0.25 | 0.38% |
|
United Kingdom |
|
33 |
USD -6.41 M
|
Dec. 31, 2023 | USD 0.06 | 0.38% |
|
United Kingdom |
|
34 |
USD -6.50 M
|
March 31, 2024 | USD 1.69 | NA |
|
United Kingdom |
|
35 |
USD -7.55 M
|
Dec. 31, 2023 | USD 0.21 | 3.52% |
|
United Kingdom |
|
36 |
USD -8.23 M
|
Dec. 31, 2023 | USD 4.20 | -6.92% |
|
United Kingdom |
|
37 |
USD -8.86 M
|
Dec. 31, 2023 | USD 0.20 | -2.58% |
|
United Kingdom |
|
38 |
USD -8.87 M
|
Dec. 31, 2023 | USD 0.05 | 0.38% |
|
United Kingdom |
|
39 |
USD -9.10 M
|
Dec. 31, 2023 | USD 0.05 | 1.59% |
|
United Kingdom |
|
40 |
USD -10.24 M
|
Dec. 31, 2023 | USD 14.61 | -1.71% |
|
United Kingdom |
|
41 |
USD -10.52 M
|
Dec. 31, 2023 | USD 1.16 | -5.69% |
|
United Kingdom |
|
42 |
USD -11.67 M
|
Dec. 31, 2023 | USD 0.70 | -3.05% |
|
United Kingdom |
|
43 |
USD -13.09 M
|
Dec. 31, 2023 | USD 0.03 | -12.38% |
|
United Kingdom |
|
44 |
USD -16.81 M
|
Dec. 31, 2023 | USD 1.09 | -19.26% |
|
United Kingdom |
|
45 |
USD -22.82 M
|
April 30, 2024 | USD 0.12 | -0.69% |
|
United Kingdom |
|
46 |
USD -27.68 M
|
Dec. 31, 2023 | USD 0.20 | -0.86% |
|
United Kingdom |
|
47 |
USD -28.42 M
|
Dec. 31, 2023 | USD 3.01 | 2.73% |
|
United Kingdom |
|
48 |
USD -31.55 M
|
Dec. 31, 2023 | USD 0.23 | 1.77% |
|
United Kingdom |
|
49 |
USD -33.99 M
|
Dec. 31, 2023 | USD 0.59 | 0.38% |
|
United Kingdom |
|
50 |
USD -39.86 M
|
Dec. 31, 2023 | USD 0.03 | -3.20% |
|
United Kingdom |
The Healthcare company in United Kingdom with the highest Operating Income is GSK plc (LSE: GSK.L) at USD 8.58 B.
The Healthcare company in United Kingdom with the lowest Operating Income is Oxford Biomedica plc (LSE: OXB.L) at USD -234.33 M.
The top 10 Healthcare companies in United Kingdom by Operating Income are GSK plc, AstraZeneca PLC, Roivant Sciences Ltd., Haleon plc, Smiths Group plc, Halma plc, Smith & Nephew plc, Hikma Pharmaceuticals PLC, Diploma PLC and ConvaTec Group Plc.
The bottom 10 Healthcare companies in United Kingdom by Operating Income are Oxford Biomedica plc, Autolus Therapeutics plc, Bicycle Therapeutics plc, Centessa Pharmaceuticals plc, COMPASS Pathways plc, LivaNova PLC, Verona Pharma plc, Silence Therapeutics plc, Immunocore Holdings plc and Alliance Pharma plc.